Maria Taboada

4.0k citations
16 papers · 855 · 2 hit papers · h-index 11

Impact in

  • Oncology top 5%
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Research Studies
    • Colorectal Cancer Treatments and Studies
    • Lung Cancer Treatments and Mutations
    • Occupational and environmental lung diseases
    • Pleural and Pulmonary Diseases
    • Lung Cancer Diagnosis and Treatment
    • Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis

Papers in

    • Prostate Cancer Treatment and Research 4
    • Occupational and environmental lung diseases 3
    • Lung Cancer Treatments and Mutations 3
    • Cancer Immunotherapy and Biomarkers 6
    • Bone health and treatments 3
    • Colorectal Cancer Treatments and Studies 2

Maria Taboada

16 papers receiving 844 citations

Maria Taboada's Hit Papers

Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC 2019 · 305 citations
3050+3+6Years since publication100200300

Peers

Maria Taboada
Comparison fields: 5 of 68
  • Oncology 510
  • Pulmonary and Respiratory Medicine 524
  • Immunology 101
  • Biotechnology 39
  • Otorhinolaryngology 19
Replace Anastasios Dimou with:
Anastasios Dimou United States
Julio Astudillo Spain
Pedro Nazareth Aguiar Brazil
Tsukihisa Yoshida Japan
Lionel Bosquée Belgium
Libor Havel Czechia
Marta Batus United States
Rossana Casaretti Italy
Qiuhua Deng China
Alexandros Xyrafas Switzerland
Maria Taboada relative to Anastasios Dimou United States Anastasios Dimou's profile →
Citations per field
00.5×3.3×
Anastasios Dimou · 1×
Citations per year

Countries citing papers authored by Maria Taboada

Since Specialization
Citations

This map shows the geographic impact of Maria Taboada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Taboada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Taboada more than expected).

Fields of papers citing papers by Maria Taboada

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Taboada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Taboada. The network helps show where Maria Taboada may publish in the future.

Co-authors

The 25 scholars most cited alongside Maria Taboada, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Maria Taboada Line = papers co-authored together Maria Taboada links everyone, so they are left out of the graph.

All Works

16 of 16 papers shown
#Work
1
Three-Year Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC—Update from PACIFIC
Hit paper breakdown →
2019305
2
Tremelimumab as second-line or third-line treatment in relapsed malignant mesothelioma (DETERMINE): a multicentre, international, randomised, double-blind, placebo-controlled phase 2b trial
Hit paper breakdown →
2017304
3 201350
4 201631
5 201127
6 202226
7 201925
8 201521
9 201116
10 201916
11 201912
12 20109
13 20108
14 20092
15 20092
16 20191

About Maria Taboada

Maria Taboada is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Surgery, Endocrinology, Diabetes and Metabolism and Biotechnology, having authored 16 papers that have together received 855 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (6 papers), Prostate Cancer Treatment and Research (4 papers), Occupational and environmental lung diseases (3 papers), Bone health and treatments (3 papers), Lung Cancer Treatments and Mutations (3 papers), Esophageal Cancer Research and Treatment (3 papers), Colorectal Cancer Treatments and Studies (2 papers) and Cancer Research and Treatments (2 papers). The work is most often cited by research in Oncology (510 citations), Pulmonary and Respiratory Medicine (524 citations), Immunology (101 citations), Biotechnology (39 citations) and Otorhinolaryngology (19 citations). Maria Taboada has collaborated with scholars based in United Kingdom, United States and Belgium. Frequent co-authors include Scott Antonia, Paul K. Stockman, Federica Grosso, Luana Calabrò, Alessandra Bearz, Dariusz M. Kowalski, Joachim G.J.V. Aerts, Anne S. Tsao, Hedy L. Kindler and Michele Maio. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, British Journal of Cancer, The Prostate and Journal of Thoracic Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact